Items where authors include "Stein, RC"

Article

Schmid, P, Abraham, J, Chan, S et al. (26 more authors) (2020) Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. Journal of Clinical Oncology, 38 (5). pp. 423-433. ISSN 0732-183X

Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2018) Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 167 (1). p. 407. ISSN 0167-6806

Hall, PS, Smith, A orcid.org/0000-0001-7709-1869, Hulme, C orcid.org/0000-0003-2077-0419 et al. (15 more authors) (2017) Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial. Value in Health, 20 (10). pp. 1311-1318. ISSN 1098-3015

Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 165 (2). pp. 343-353. ISSN 0167-6806

Cameron, D, Morden, JP, Canney, P et al. (21 more authors) (2017) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology, 18 (7). pp. 929-945. ISSN 1470-2045

Hall, P, Smith, AFC, Vargas-Palacios, A et al. (20 more authors) (2015) UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer. Cancer Research, 75 (9). Abstract P6-08-11. ISSN 0008-5472

Hall, PS, McCabe, C, Stein, RC et al. (1 more author) (2012) Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer. Journal of the National Cancer Institute, 104 (1). 56 - 66. ISSN 0027-8874

Conference or Workshop Item

Stein, RC, Makris, A, MacPherson, IR et al. (17 more authors) (2021) Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population. In: 2021 ASCO Annual Meeting, 04-08 Jun 2021, Virtual.

Schmid, P, Abraham, J, Chan, S et al. (17 more authors) (2018) AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial. In: 2018 ASCO Annual Meeting, 01-05 Jun 2018, Chicago, IL, USA.